# Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus

> **NCT01154348** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 34 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** S-707106
- **DRUG:** Placebo
- **DRUG:** Metformin, S-707106 plus metformin
- **DRUG:** Metformin, placebo plus metformin

## Key facts

- **NCT ID:** NCT01154348
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01154348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01154348, "Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01154348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*